Samsung Medical Center
Colon cancer treatment cost in Republic of Korea is significantly lower than in the United States, with a PET-CT scan typically running from Price on request to Price on request . Surgical options like a colectomy (large bowel resection) range from $16,500 to $29,800, while advanced robotic surgery using the Da Vinci Robotic System costs $12,000 to $19,500. Total expenses depend on the cancer stage and technology used. Patients often see 40-60% savings compared to the US. Seoul is the primary destination for this treatment.
Typical Colon Cancer Treatment Costs in Republic of Korea
Bookimed Expert Insight: Patients seeking the highest survival rates should consider JCI-accredited state facilities in Seoul. Seoul National University Hospital (SNUH) reports the highest cancer treatment statistics in the country. For complex cases requiring precision, Samsung Medical Center offers presidential-standard care with Novalis and IGRT technologies. Robotic surgery is ideal for reducing recovery time. Korea University Anam Hospital performed the first successful robotic bladder cancer surgery in Asia, demonstrating exceptional surgical expertise.
| Republic of Korea | Turkey | Austria | |
| NanoKnife | from $17,500 | from $9,500 | from $25,000 |
| Hyperthermic Intraperitoneal Chemotherapy (HIPEC) | from $23,500 | from $6,500 | from $40,000 |
| Gastric polyps removal | from $2,800 | from $760 | from $5,000 |
| Da Vinci Robotic System | from $12,000 | from $12,000 | from $22,000 |
| CyberKnife | from $11,500 | from $4,750 | from $50,000 |
Dr. Yu Yeonghun is a gastrointestinal surgeon with a Ph.D. in Medicine. He specializes in hepato-pancreato-biliary (HPB) diseases and cancers. His focus includes liver, pancreas, biliary tract, and gallbladder cancers, as well as cholelithiasis and other gallbladder diseases.
He completed his internship and general surgery residency at CHA Bundang Medical Center. He then finished an HPB surgery fellowship at Samsung Medical Center. He has served as Clinical Assistant Professor of Surgery at Konkuk University Choongju Hospital and at Samsung Medical Center. He later became Professor of Surgery at Eulji University Hospital.
He is a Lifetime Member of The Korean Surgical Society and the Korean Association of Hepato-Biliary-Pancreatic Surgery (KAHBPS). He serves on the KAHBPS Planning Committee and Tumor Registry Committee.
Dr. Kim Taekhyeon is a gastrointestinal surgeon and the Chief of Gastrointestinal Surgery at Naeun Hospital. He received his M.D. and M.S. from Chung-Ang University College of Medicine. He completed an internship at Sungae Hospital and a general surgery residency at Chung-Ang University Hospital. He then finished a fellowship in gastrointestinal surgery at Seoul St. Mary’s Hospital. He previously served as an attending surgeon at Gwangmyeong Sungae Hospital.
His research covers survivin and HSP90 in colorectal cancer, second primary cancers in patients with gastric cancer, and Borrmann type IV gastric carcinoma. He reported outcomes of laparoscopic totally extraperitoneal inguinal hernia repair in 92 cases. His clinical practice includes cancers and diseases of the stomach, esophagus, and small bowel. He also treats hernias, gallstones and cholecystitis, appendicitis, anal disease, varicose veins, and burns.
Dr. Park Sundo is a specialist in gastrointestinal and general surgery at Naeun Hospital. His expertise includes colorectal, proctology, breast, thyroid, laparoscopic, biliary, pancreatic, and pediatric surgery.
Key treatments include proctologic surgery, such as hemorrhoidectomy and care for hemorrhoids and anal fistula. He performs laparoscopic surgery for gallstones (cholelithiasis) and appendicitis. His oncology care covers gastric and colorectal cancer. He also performs hernia repair. Breast and thyroid care includes treatment of tumors and Mammotome biopsy. He treats varicose veins and severe burns. Pediatric surgery includes hernia repair and general pediatric procedures.
Professor Kyu Taek Lee is a top gastroenterologist specializing in pancreatic, bile duct, and gallbladder cancers at Samsung Medical Center.
South Korea maintains a 73.7% 5-year relative survival rate for all cancers, ranking among the highest globally. The country outperforms the OECD average in avoidable mortality. Colorectal cancer survival is particularly high, with localized-stage cases showing success rates of 92.7%.
Bookimed Expert Insight: South Korea handles a massive patient volume that directly drives its high survival statistics. For example, Samsung Medical Center and Seoul National University Bundang Hospital manage over 1,500,000 patients each year. This concentrated experience allows surgeons to refine robotic techniques, which results in higher precision and faster recovery for cancer patients.
Patient Consensus: Patients often credit Korea's routine screening culture for catching cancer earlier than in Western countries. Many find that robotic surgery access is faster here, which they feel contributes to lower recurrence rates and better peace of mind.
South Korean hospitals treat colon cancer using minimally invasive surgical techniques, standardized chemotherapy, and targeted immunotherapy. Over 85% of procedures utilize laparoscopic or robotic-assisted methods. Specialized centers provide precision options like Da Vinci robotic-assisted colectomy, heated chemotherapy during surgery, and rapid genetic profiling for personalized medicine plans.
Bookimed Expert Insight: Samsung Medical Center and Seoul National University Hospital leverage massive patient volumes to refine surgical precision. Samsung alone serves over 2,000,000 patients annually. This high frequency allows surgeons to maintain specialized skill sets. For example, some Korean centers achieve over 90% anal sphincter preservation in rectal cancer cases.
Patient Consensus: Patients note that recovery is faster than in Western countries. Many report being discharged 3–4 days after robotic-assisted surgery. They emphasize the importance of bringing probiotics to manage digestion issues after a colectomy.
Leading South Korean hospitals for colon cancer include Samsung Medical Center and Asan Medical Center. These facilities offer advanced colectomy procedures and robotic surgery using the Da Vinci system. Most top centers hold JCI and KOIHA accreditations. They maintain high survival rates and serve millions of patients annually.
Bookimed Expert Insight: Samsung Medical Center and Asan Medical Center are consistent leaders in Newsweek rankings. Samsung Medical Center is noted for providing presidential-standard care to over 2 million patients yearly. These institutions integrate AI and digital imaging into colorectal pathology to ensure diagnosis accuracy before surgery.
Patient Consensus: Patients note the efficiency of Korean hospitals. Many highlight how quickly they moved from initial diagnostic PET scans to surgical treatment without long delays.
International patients for colon cancer treatment in South Korea should expect a stay of 14 to 28 days. This timeframe covers the preoperative diagnostic protocol, surgical intervention, and mandatory recovery. Major abdominal procedures require 10 to 14 days of local recuperation before safe air travel is possible.
Bookimed Expert Insight: Data from major Seoul centers shows a clear preference for digital integration to shorten stays. Facilities like Seoul National University Bundang Hospital use the BESTcare system to streamline coordination. This allows international patients to complete comprehensive staging and surgery within a tighter 14-day window. This is significantly faster than the 21-day average seen in non-digitalized regional oncology hubs.
Patient Consensus: Patients note it is vital to overplan your stay by at least 1 week. This extra time helps if minor issues like bowel fatigue or infections occur during recovery.
South Korea offers cutting-edge advances in colon cancer care through the integration of artificial intelligence and advanced regenerative medicine. Patients access sophisticated techniques like Da Vinci robotic surgery and NanoKnife electroporation. Recent regulatory changes also allow the fee-based use of investigational gene and cell therapies.
Bookimed Expert Insight: Korea’s digital hospital infrastructure provides a unique safety advantage for international patients. Facilities like Seoul National University Bundang Hospital use the BESTcare system to prevent medical errors. High-volume centers like Asan Medical Center perform over 65,000 operations annually. This massive volume ensures surgeons maintain elite proficiency in complex colorectal procedures.
Patient Consensus: Patients are often impressed by the speed of diagnostic workups and the seamless use of hospital apps. Many note that the high-tech environment feels efficient, though the pace in large Seoul clinics can feel very fast.